Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DURECT Corporation - Common Stock (NQ:DRRX)

1.880 +0.020 (+1.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 809,207
Open 1.850
Bid (Size) 1.880 (10)
Ask (Size) 1.900 (3)
Prev. Close 1.860
Today's Range 1.850 - 1.890
52wk Range 0.4801 - 2.640
Shares Outstanding 24,489,843
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks are being observed in Wednesday's session.
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Fraud Regulatory Compliance

Performance

YTD
+137.7%
+137.7%
1 Month
+201.3%
+201.3%
3 Month
+186.6%
+186.6%
6 Month
+138.3%
+138.3%
1 Year
+43.5%
+43.5%

More News

Read More
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
An Overview of Durect's Earnings
Via Benzinga
Earnings Preview: Durect
Via Benzinga
Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views
Via Benzinga
Topics Earnings
US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings
Via Benzinga
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Durect: Q4 Earnings Insights
Via Benzinga
Durect's Earnings: A Preview
Via Benzinga
Shareholder Alert: The Ademi Firm Investigates Whether DURECT Corporation Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Earnings Scheduled For March 26, 2025
Via Benzinga
DRRX Stock Earnings: Durect Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
DRRX Stock Earnings: Durect Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
DRRX Stock Earnings: Durect Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 27, 2024
Via Benzinga
Top 3 Health Care Stocks That Are Preparing To Pump This Month
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is DURECT Corporation - Common Stock publicly traded?
Yes, DURECT Corporation - Common Stock is publicly traded.
What exchange does DURECT Corporation - Common Stock trade on?
DURECT Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DURECT Corporation - Common Stock?
The ticker symbol for DURECT Corporation - Common Stock is DRRX on the Nasdaq Stock Market
What is the current price of DURECT Corporation - Common Stock?
The current price of DURECT Corporation - Common Stock is 1.880
When was DURECT Corporation - Common Stock last traded?
The last trade of DURECT Corporation - Common Stock was at 08/07/25 04:00 PM ET
What is the market capitalization of DURECT Corporation - Common Stock?
The market capitalization of DURECT Corporation - Common Stock is 46.04M
How many shares of DURECT Corporation - Common Stock are outstanding?
DURECT Corporation - Common Stock has 46M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.